UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Upregulation of PD-1 and its ligands and expansion of T peripheral helper cells in the nephritic kidneys of lupus-prone BXSB-Yaa mice

Lupus, 2024-07, Vol.33 (8), p.816-827

2024

Volltextzugriff (PDF)

Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease

Rheumatology (Oxford, England), 2014-12, Vol.53 (12), p.2196-2203

2014

Volltextzugriff (PDF)

Serum levels of soluble programmed cell death protein 1 and soluble programmed cell death protein ligand 2 are increased in systemic lupus erythematosus and associated with the disease activity

Lupus, 2020-06, Vol.29 (7), p.686-696

2020

Volltextzugriff (PDF)

Analysis for efficiency potential of high‐efficiency and next‐generation solar cells

Progress in photovoltaics, 2018-08, Vol.26 (8), p.543-552

2018

Volltextzugriff (PDF)

Efficiency potential and recent activities of high-efficiency solar cells

Journal of materials research, 2017-09, Vol.32 (18), p.3445-3457

2017

Volltextzugriff (PDF)

Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesions

Arthritis research & therapy, 2020-04, Vol.22 (1), p.72-12, Article 72

2020

Volltextzugriff (PDF)

KL-6 is a long-term disease-activity biomarker for interstitial lung disease associated with polymyositis/dermatomyositis, but is not a short-term disease-activity biomarker

Modern rheumatology, 2019-07, Vol.29 (4), p.625-632

2019

Volltextzugriff (PDF)

Interstitial Lung Disease with ANCA-associated Vasculitis

Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, 2015-01, Vol.2015 (S1), p.51-56

2015

Volltextzugriff (PDF)

Trends in actual medication use for child-onset systemic lupus erythematosus using the Japanese health insurance database 2009-18

Modern rheumatology, 2022-04, Vol.32 (3), p.565-570

2022

Volltextzugriff (PDF)

Comparisons between US norm-based two-component and Japanese norm-based three-component SF-36 summary scores in systemic lupus erythematosus patients

Modern rheumatology, 2023-04, Vol.33 (3), p.517-524

2023

Volltextzugriff (PDF)

Antifibrotic effects of 2-carba cyclic phosphatidic acid (2ccPA) in systemic sclerosis: contribution to the novel treatment

Arthritis research & therapy, 2019-04, Vol.21 (1), p.103-103, Article 103

2019

Volltextzugriff (PDF)

Frequency of class III and IV nephritis in systemic lupus erythematosus without clinical renal involvement: an analysis of predictive measures

Journal of rheumatology, 2012-01, Vol.39 (1), p.79-85

2012

Volltextzugriff (PDF)

Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study

The Lancet. Rheumatology, 2019-10, Vol.1 (2), p.e95-e102

2019

Volltextzugriff (PDF)

Nation-wide survey of the treatment trend of microscopic polyangiitis and granulomatosis with polyangiitis in Japan using the Japanese Ministry of Health, Labour and Welfare Database

Modern rheumatology, 2022-08, Vol.32 (5), p.915-922

2022

Volltextzugriff (PDF)

Tumour necrosis factor inhibitor-induced myositis in a patient with ulcerative colitis

Modern rheumatology case reports, 2021, Vol.5 (1), p.156-161

2021

Volltextzugriff (PDF)

Role of innate immunity in a murine model of histidyl–transfer RNA synthetase (Jo‐1)–mediated myositis

Arthritis & rheumatology (Hoboken, N.J.), 2011-02, Vol.63 (2), p.479-487

2011

Volltextzugriff (PDF)

Evaluation of remission definitions for systemic lupus erythematosus: a prospective cohort study

The Lancet. Rheumatology, 2019-10, Vol.1 (2), p.e103-e110

2019

Volltextzugriff (PDF)

Clinical manifestations of neurological involvement in primary Sjögren’s syndrome

Clinical rheumatology, 2011-04, Vol.30 (4), p.485-490

2011

Volltextzugriff (PDF)

Systematic review and meta-analysis for 2017 clinical practice guidelines of the Japan research committee of the ministry of health, labour, and welfare for intractable vasculitis for the management of ANCA-associated vasculitis

Modern rheumatology, 2019-01, Vol.29 (1), p.119-129

2019

Volltextzugriff (PDF)

Development of the Asia Pacific Lupus Collaboration cohort

International journal of rheumatic diseases, 2019-03, Vol.22 (3), p.425-433

2019

Volltextzugriff (PDF)

Clinical usefulness of anti-M-type phospholipase-A-receptor antibodies in patients with membranous nephropathy and the comparison of three quantification methods

Immunological medicine, 2020-03, Vol.43 (1), p.47-56

2020

Volltextzugriff (PDF)

New-onset psychiatric disorders after corticosteroid therapy in systemic lupus erythematosus: an observational case-series study

Journal of neurology, 2014-11, Vol.261 (11), p.2150-2158

2014

Volltextzugriff (PDF)

A case of Takayasu arteritis complicated with acute pericarditis at initial presentation

Modern rheumatology case reports, 2023-01, Vol.7 (1), p.154-159

2023

Volltextzugriff (PDF)

NR2‐reactive antibody decreases cell viability through augmentation of Ca2+ influx in systemic lupus erythematosus

Arthritis & rheumatology (Hoboken, N.J.), 2011-12, Vol.63 (12), p.3952-3959

2011

Volltextzugriff (PDF)

1 – 25 von 313

Suche als RSS-Feed

Aktive Filter

PublikationsformArtikel

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(264)
Mit Volltextzugriff
(261)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(200)
Life Sciences & Biomedicine
(167)
Humans
(142)
Female
(110)
Middle Aged
(85)
Adult
(84)
Rheumatology
(75)
Male
(67)
Aged
(59)
Oncology
(54)
Biological And Medical Sciences
(46)
Medical Sciences
(44)
Retrospective Studies
(37)
Treatment Outcome
(36)
Medicine
(33)
Systemic Lupus Erythematosus
(33)
Medicine & Public Health
(31)
Physical Sciences
(30)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(27)
Chemotherapy
(23)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Upregulation of PD-1 and its ligands and expansion of T peripheral helper cells in the nephritic kidneys of lupus-prone BXSB-Yaa mice

Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease

Serum levels of soluble programmed cell death protein 1 and soluble programmed cell death protein ligand 2 are increased in systemic lupus erythematosus and associated with the disease activity

Analysis for efficiency potential of high‐efficiency and next‐generation solar cells

Efficiency potential and recent activities of high-efficiency solar cells

Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesions

KL-6 is a long-term disease-activity biomarker for interstitial lung disease associated with polymyositis/dermatomyositis, but is not a short-term disease-activity biomarker

Interstitial Lung Disease with ANCA-associated Vasculitis

Trends in actual medication use for child-onset systemic lupus erythematosus using the Japanese health insurance database 2009-18

'Not at target': prevalence and consequences of inadequate disease control in systemic lupus erythematosus-a multinational observational cohort study

Comparisons between US norm-based two-component and Japanese norm-based three-component SF-36 summary scores in systemic lupus erythematosus patients

Antifibrotic effects of 2-carba cyclic phosphatidic acid (2ccPA) in systemic sclerosis: contribution to the novel treatment

Frequency of class III and IV nephritis in systemic lupus erythematosus without clinical renal involvement: an analysis of predictive measures

Lupus low disease activity state as a treatment endpoint for systemic lupus erythematosus: a prospective validation study

Nation-wide survey of the treatment trend of microscopic polyangiitis and granulomatosis with polyangiitis in Japan using the Japanese Ministry of Health, Labour and Welfare Database

Tumour necrosis factor inhibitor-induced myositis in a patient with ulcerative colitis

Role of innate immunity in a murine model of histidyl–transfer RNA synthetase (Jo‐1)–mediated myositis

Evaluation of remission definitions for systemic lupus erythematosus: a prospective cohort study

Clinical manifestations of neurological involvement in primary Sjögren’s syndrome

Systematic review and meta-analysis for 2017 clinical practice guidelines of the Japan research committee of the ministry of health, labour, and welfare for intractable vasculitis for the management of ANCA-associated vasculitis

Development of the Asia Pacific Lupus Collaboration cohort

Clinical usefulness of anti-M-type phospholipase-A-receptor antibodies in patients with membranous nephropathy and the comparison of three quantification methods

New-onset psychiatric disorders after corticosteroid therapy in systemic lupus erythematosus: an observational case-series study

A case of Takayasu arteritis complicated with acute pericarditis at initial presentation

NR2‐reactive antibody decreases cell viability through augmentation of Ca2+ influx in systemic lupus erythematosus

Aktive Filter

Suchergebnisse filtern